Literature DB >> 24649053

Network analysis of microRNAs, genes and their regulation in human bladder cancer.

Yang Li1, Zhiwen Xu1, Kunhao Wang1, Ning Wang1, Minghui Zhu1.   

Abstract

Bladder cancer (BC) is the fifth most common malignancy occurring worldwide and a significant cause of cancer-related morbidity and mortality. Although BC is a serious health issue, studies available concerning the relationship of genes, microRNAs (miRNAs) and their host genes has been lacking. In the present study, we assessed experimentally validated data from various sources that reported the effect of miRNA on various diseases, miRNA targeting of mRNAs, and combined these data with initial transcription factor (TF) binding site predictions within miRNA promoter regions. Topology networks obtained in this study included the differentially expressed, BC-associated and global networks. The three networks may be used to assess the effect of miRNAs and their regulation in human BC. By comparing and analyzing the similarities and differences among the three networks, key nodes with the largest potential of affecting the behavior of a particular network were identified. The results also showed potentially substantially influential miRNAs and TFs, which revealed subnetworks demonstrating the mechanisms involved as well as regulatory miRNA network motifs in human BC. Regulatory pathways regarding differentially expressed elements, such as genes and miRNAs, demonstrate self-adapting associations including, self-adapting associations and feedback loops in genes MYC, TP53, PTEN and 10 differentially expressed miRNAs. The differentially expressed network partially identified the BC mechanism. miRNA-targeted human BC genes were also enriched in highly relevant pathways, cell cycle regulation and apoptosis. The present study systematically delineated the pathogenesis of BC and provided theoretical foundations for gene therapy investigators to focu attention on key genes and miRNAs in future studies.

Entities:  

Keywords:  bladder cancer; host gene; microRNA; target; target genes; transcription factors

Year:  2013        PMID: 24649053      PMCID: PMC3916994          DOI: 10.3892/br.2013.157

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  20 in total

1.  TarBase: A comprehensive database of experimentally supported animal microRNA targets.

Authors:  Praveen Sethupathy; Benoit Corda; Artemis G Hatzigeorgiou
Journal:  RNA       Date:  2005-12-22       Impact factor: 4.942

2.  Gene regulation by transcription factors and microRNAs.

Authors:  Oliver Hobert
Journal:  Science       Date:  2008-03-28       Impact factor: 47.728

Review 3.  Bladder cancer: epidemiology, diagnosis, and management.

Authors:  Chris Leo Pashos; Marc F Botteman; Benjamin Lewis Laskin; Alberto Redaelli
Journal:  Cancer Pract       Date:  2002 Nov-Dec

4.  Cancer statistics, 2005.

Authors:  Ahmedin Jemal; Taylor Murray; Elizabeth Ward; Alicia Samuels; Ram C Tiwari; Asma Ghafoor; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2005 Jan-Feb       Impact factor: 508.702

5.  Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia.

Authors:  George Adrian Calin; Calin Dan Dumitru; Masayoshi Shimizu; Roberta Bichi; Simona Zupo; Evan Noch; Hansjuerg Aldler; Sashi Rattan; Michael Keating; Kanti Rai; Laura Rassenti; Thomas Kipps; Massimo Negrini; Florencia Bullrich; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-14       Impact factor: 11.205

6.  A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomas.

Authors:  A Girling; J Bartkova; J Burchell; S Gendler; C Gillett; J Taylor-Papadimitriou
Journal:  Int J Cancer       Date:  1989-06-15       Impact factor: 7.396

7.  FGFR3, HRAS, KRAS, NRAS and PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapy.

Authors:  Lucie C Kompier; Irene Lurkin; Madelon N M van der Aa; Bas W G van Rhijn; Theo H van der Kwast; Ellen C Zwarthoff
Journal:  PLoS One       Date:  2010-11-03       Impact factor: 3.240

8.  Identification of mammalian microRNA host genes and transcription units.

Authors:  Antony Rodriguez; Sam Griffiths-Jones; Jennifer L Ashurst; Allan Bradley
Journal:  Genome Res       Date:  2004-09-13       Impact factor: 9.043

9.  The UCSC Genome Browser database: extensions and updates 2011.

Authors:  Timothy R Dreszer; Donna Karolchik; Ann S Zweig; Angie S Hinrichs; Brian J Raney; Robert M Kuhn; Laurence R Meyer; Mathew Wong; Cricket A Sloan; Kate R Rosenbloom; Greg Roe; Brooke Rhead; Andy Pohl; Venkat S Malladi; Chin H Li; Katrina Learned; Vanessa Kirkup; Fan Hsu; Rachel A Harte; Luvina Guruvadoo; Mary Goldman; Belinda M Giardine; Pauline A Fujita; Mark Diekhans; Melissa S Cline; Hiram Clawson; Galt P Barber; David Haussler; W James Kent
Journal:  Nucleic Acids Res       Date:  2011-11-15       Impact factor: 16.971

10.  miR2Disease: a manually curated database for microRNA deregulation in human disease.

Authors:  Qinghua Jiang; Yadong Wang; Yangyang Hao; Liran Juan; Mingxiang Teng; Xinjun Zhang; Meimei Li; Guohua Wang; Yunlong Liu
Journal:  Nucleic Acids Res       Date:  2008-10-15       Impact factor: 16.971

View more
  8 in total

1.  A non-invasive miRNA based assay to detect bladder cancer in cell-free urine.

Authors:  Jessica De Long; Travis B Sullivan; John Humphrey; Tanya Logvinenko; Kelly A Summerhayes; Spencer Kozinn; Niall Harty; Ian C Summerhayes; John A Libertino; Antonia H Holway; Kimberly M Rieger-Christ
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

2.  Regulatory networks in retinal ischemia-reperfusion injury.

Authors:  Kalina Andreeva; Maha M Soliman; Nigel G F Cooper
Journal:  BMC Genet       Date:  2015-04-24       Impact factor: 2.797

Review 3.  MicroRNAs as biomarkers associated with bladder cancer.

Authors:  Amene Homami; Farideh Ghazi
Journal:  Med J Islam Repub Iran       Date:  2016-12-29

Review 4.  Dysregulation of miRNAs in bladder cancer: altered expression with aberrant biogenesis procedure.

Authors:  Fan Dong; Tianyuan Xu; Yifan Shen; Shan Zhong; Shanwen Chen; Qiang Ding; Zhoujun Shen
Journal:  Oncotarget       Date:  2017-04-18

Review 5.  Clinical Application of Circulating MicroRNAs in Parkinson's Disease: The Challenges and Opportunities as Diagnostic Biomarker.

Authors:  Palaniswamy Ramaswamy; Ravi Yadav; Pramod Kumar Pal; Rita Christopher
Journal:  Ann Indian Acad Neurol       Date:  2020-01-21       Impact factor: 1.383

6.  CircPTPRA blocks the recognition of RNA N6-methyladenosine through interacting with IGF2BP1 to suppress bladder cancer progression.

Authors:  Fei Xie; Chao Huang; Feng Liu; Hui Zhang; Xingyuan Xiao; Jiayin Sun; Xiaoping Zhang; Guosong Jiang
Journal:  Mol Cancer       Date:  2021-04-14       Impact factor: 27.401

7.  Detection of Differentially Expressed MicroRNAs in Rheumatic Heart Disease: miR-1183 and miR-1299 as Potential Diagnostic Biomarkers.

Authors:  Ni Li; Jiangfang Lian; Sheng Zhao; Dawei Zheng; Xi Yang; Xiaoyan Huang; Xinbao Shi; Lebo Sun; Qingyun Zhou; Huoshun Shi; Guodong Xu; Enchill KoJo Incoom; Jianqing Zhou; Guofeng Shao
Journal:  Biomed Res Int       Date:  2015-10-11       Impact factor: 3.411

8.  The effect of inhibition of PP1 and TNFα signaling on pathogenesis of SARS coronavirus.

Authors:  Jason E McDermott; Hugh D Mitchell; Lisa E Gralinski; Amie J Eisfeld; Laurence Josset; Armand Bankhead; Gabriele Neumann; Susan C Tilton; Alexandra Schäfer; Chengjun Li; Shufang Fan; Shannon McWeeney; Ralph S Baric; Michael G Katze; Katrina M Waters
Journal:  BMC Syst Biol       Date:  2016-09-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.